Generation Bio Co. (GBIO) Revenue History
Annual and quarterly revenue from 2018 to 2024
Compound Annual Growth Rate (CAGR)
Loading revenue history...
GBIO Revenue Growth
Revenue Breakdown (FY 2024)
GBIO's revenue distribution by segment and geography for fiscal year 2024
By Product/Segment
GBIO Revenue Analysis (2018–2024)
As of May 9, 2026, Generation Bio Co. (GBIO) generated trailing twelve-month (TTM) revenue of $15.3 million, reflecting significant decline in growth of -78.9% year-over-year. The most recent quarter (Q3 2025) recorded $1.6 million in revenue, up 108.4% sequentially.
Looking at the longer-term picture, GBIO's historical revenue data shows various trends over time. The company achieved its highest annual revenue of $19.9 million in 2024, representing a new all-time high.
Revenue diversification analysis shows GBIO's business is primarily driven by One Reportable Segment (100%). With over half of revenue concentrated in One Reportable Segment, the company maintains significant focus in this area while developing other growth vectors.
When compared to Healthcare sector peers including ARWR (+14.1% YoY), RARE (+13.3% YoY), and FOLD (+20.0% YoY), GBIO has underperformed the peer group in terms of revenue growth. Compare GBIO vs ARWR →
GBIO Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| GBIOCurrent | $15M | -78.9% | - | -715.8% | |
 ARWR | $829M | +14.1% | +56.6% | 11.9% | |
 RARE | $673M | +13.3% | +19.9% | -79.5% | |
 FOLD | $634M | +20.0% | +19.4% | 5.4% | |
 KRYS | $389M | +25.1% | - | 41.5% |
GBIO Historical Revenue Data (2018–2024)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2024 | $19.9M | +236.9% | $19.9M | 100.0% | $-142,390,000 | -715.8% |
| 2023 | $5.9M | - | $5.9M | 100.0% | $-138,563,000 | -2346.9% |
| 2022 | $0 | - | $0 | - | $-141,182,000 | - |
| 2021 | $0 | - | $0 | - | $-119,101,000 | - |
| 2020 | $0 | - | $-3,432,000 | - | $-81,114,000 | - |
| 2019 | $0 | -100.0% | $-1,864,000 | - | $-62,302,000 | - |
| 2018 | $36K | - | $36K | 100.0% | $-37,294,000 | -103594.4% |
See GBIO's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs GBIO Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare GBIO vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonGBIO — Frequently Asked Questions
Quick answers to the most common questions about buying GBIO stock.
Is GBIO's revenue growth accelerating or slowing?
GBIO revenue declined -78.9% year-over-year, contrasting with the 5-year CAGR of N/A. TTM revenue fell to $15M. This reverses the prior growth trend.
What is GBIO's long-term revenue growth rate?
Generation Bio Co.'s 5-year revenue CAGR of N/A reflects the variable expansion pattern. Current YoY growth of -78.9% is below this long-term average.
How is GBIO's revenue distributed by segment?
GBIO reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2018-2024 are available for download. Segment mix reveals concentration and diversification trends.